# Antithrombotic Strategy for AF Patients With High Risk CAD

> **NCT06866665** · NA · NOT_YET_RECRUITING · sponsor: **Yonsei University** · enrollment: 1400 (estimated)

## Conditions studied

- Atrial Fibrillation
- Coronary Artery Disease

## Interventions

- **DRUG:** Anticoagulation Monotherapy
- **DRUG:** Combination therapy

## Key facts

- **NCT ID:** NCT06866665
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-03
- **Primary completion:** 2030-12
- **Final completion:** 2030-12
- **Target enrollment:** 1400 (ESTIMATED)
- **Last updated:** 2025-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06866665

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06866665, "Antithrombotic Strategy for AF Patients With High Risk CAD". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT06866665. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*